Levi M - Search Results

1

Influenza vaccines for preventing coronary heart disease.

Keller T, Weeda VB, van Dongen CJ, Levi M. Keller T, et al. Among authors: levi m. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005050. doi: 10.1002/14651858.CD005050.pub2. Cochrane Database Syst Rev. 2008. Update in: Cochrane Database Syst Rev. 2015 May 05;(5):CD005050. doi: 10.1002/14651858.CD005050.pub3 PMID: 18646119 Updated. Review.

2

Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.

Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E, Büller HR. Levi M, et al. Lancet. 1999 Dec 4;354(9194):1940-7. doi: 10.1016/S0140-6736(99)01264-7. Lancet. 1999. PMID: 10622296

3

Low-molecular weight heparins in venous and arterial thrombotic disease.

Bijsterveld NR, Hettiarachchi R, Peters R, Prins MH, Levi M, Büller HR. Bijsterveld NR, et al. Among authors: levi m. Thromb Haemost. 1999 Sep;82 Suppl 1:139-47. Thromb Haemost. 1999. PMID: 10695506

4

Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor.

Friederich PW, Keller TT, Biemond BJ, Peters RJ, Hornberger W, Büller HR, Levi M. Friederich PW, et al. Among authors: levi m. Thromb Haemost. 2000 Nov;84(5):858-64. Thromb Haemost. 2000. PMID: 11127868

5

Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.

Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Büller HR. Friederich PW, et al. Among authors: levi m. Circulation. 2001 May 29;103(21):2555-9. doi: 10.1161/01.cir.103.21.2555. Circulation. 2001. PMID: 11382723 Clinical Trial.

6

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.

Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Büller HR, Levi M. Friederich PW, et al. Among authors: levi m. Lancet. 2003 Jan 18;361(9353):201-5. doi: 10.1016/S0140-6736(03)12268-4. Lancet. 2003. PMID: 12547542 Clinical Trial.

7

Infection and inflammation and the coagulation system.

Levi M, Keller TT, van Gorp E, ten Cate H. Levi M, et al. Cardiovasc Res. 2003 Oct 15;60(1):26-39. doi: 10.1016/s0008-6363(02)00857-x. Cardiovasc Res. 2003. PMID: 14522404 Review.

8

Infections and endothelial cells.

Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC. Keller TT, et al. Among authors: levi m. Cardiovasc Res. 2003 Oct 15;60(1):40-8. doi: 10.1016/s0008-6363(03)00354-7. Cardiovasc Res. 2003. PMID: 14522405 Review.

9

Recombinant factor VIIa as an antidote for anticoagulant treatment.

Levi M, Bijsterveld NR, Keller TT. Levi M, et al. Semin Hematol. 2004 Jan;41(1 Suppl 1):65-9. doi: 10.1053/j.seminhematol.2003.11.013. Semin Hematol. 2004. PMID: 14872424 Review.

10

Low-molecular-weight heparin as bridging anticoagulation.

van Dongen CJ, Vink R, Levi M. van Dongen CJ, et al. Among authors: levi m. Arch Intern Med. 2004 Dec 13-27;164(22):2500. doi: 10.1001/archinte.164.22.2500-a. Arch Intern Med. 2004. PMID: 15596646 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,859 results

Search Page

Filters